nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—Triamcinolone—multiple sclerosis	0.182	0.424	CbGbCtD
Aminosalicylic Acid—PTGS2—Betamethasone—multiple sclerosis	0.156	0.364	CbGbCtD
Aminosalicylic Acid—PTGS2—Dexamethasone—multiple sclerosis	0.0907	0.212	CbGbCtD
Aminosalicylic Acid—Non-Hodgkin's lymphoma—Fingolimod—multiple sclerosis	0.0152	0.0616	CcSEcCtD
Aminosalicylic Acid—Lymphoma—Fingolimod—multiple sclerosis	0.0152	0.0616	CcSEcCtD
Aminosalicylic Acid—Non-Hodgkin's lymphoma—Azathioprine—multiple sclerosis	0.00699	0.0284	CcSEcCtD
Aminosalicylic Acid—Lymphoma—Azathioprine—multiple sclerosis	0.00699	0.0284	CcSEcCtD
Aminosalicylic Acid—Malabsorption—Methotrexate—multiple sclerosis	0.00678	0.0275	CcSEcCtD
Aminosalicylic Acid—Non-Hodgkin's lymphoma—Mitoxantrone—multiple sclerosis	0.00565	0.0229	CcSEcCtD
Aminosalicylic Acid—Taste metallic—Methotrexate—multiple sclerosis	0.00309	0.0126	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Fingolimod—multiple sclerosis	0.00301	0.0122	CcSEcCtD
Aminosalicylic Acid—Lymphoma—Methotrexate—multiple sclerosis	0.00282	0.0114	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Prednisolone—multiple sclerosis	0.00263	0.0107	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Azathioprine—multiple sclerosis	0.0025	0.0102	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Cladribine—multiple sclerosis	0.00244	0.0099	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Prednisolone—multiple sclerosis	0.00242	0.00984	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Triamcinolone—multiple sclerosis	0.00242	0.00984	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Methylprednisolone—multiple sclerosis	0.00242	0.00981	CcSEcCtD
Aminosalicylic Acid—Haemolytic anaemia—Cladribine—multiple sclerosis	0.00242	0.00981	CcSEcCtD
Aminosalicylic Acid—Pericarditis—Methotrexate—multiple sclerosis	0.00228	0.00924	CcSEcCtD
Aminosalicylic Acid—Purpura—Cladribine—multiple sclerosis	0.00226	0.00919	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Triamcinolone—multiple sclerosis	0.00223	0.00905	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Methylprednisolone—multiple sclerosis	0.00222	0.00903	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Betamethasone—multiple sclerosis	0.0022	0.00892	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Dexamethasone—multiple sclerosis	0.0022	0.00892	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Prednisolone—multiple sclerosis	0.00219	0.00889	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Fingolimod—multiple sclerosis	0.00207	0.00842	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Dexamethasone—multiple sclerosis	0.00202	0.00821	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Betamethasone—multiple sclerosis	0.00202	0.00821	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Triamcinolone—multiple sclerosis	0.00201	0.00817	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00196	0.00795	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Prednisone—multiple sclerosis	0.00191	0.00777	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Fingolimod—multiple sclerosis	0.00185	0.00753	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Fingolimod—multiple sclerosis	0.00184	0.00746	CcSEcCtD
Aminosalicylic Acid—Hypothyroidism—Prednisone—multiple sclerosis	0.00183	0.00745	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Prednisone—multiple sclerosis	0.00176	0.00715	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Prednisolone—multiple sclerosis	0.00166	0.00674	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00163	0.00663	CcSEcCtD
Aminosalicylic Acid—Eruption—Methotrexate—multiple sclerosis	0.0016	0.0065	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Prednisone—multiple sclerosis	0.00159	0.00646	CcSEcCtD
Aminosalicylic Acid—Encephalopathy—Methotrexate—multiple sclerosis	0.00153	0.00622	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Triamcinolone—multiple sclerosis	0.00153	0.0062	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Methylprednisolone—multiple sclerosis	0.00152	0.00618	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Cladribine—multiple sclerosis	0.00149	0.00605	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Cladribine—multiple sclerosis	0.00148	0.00601	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.00145	0.159	CbGdCrCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Mitoxantrone—multiple sclerosis	0.00143	0.00582	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.00143	0.156	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.00143	0.156	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.0014	0.153	CbGdCrCtD
Aminosalicylic Acid—Vasculitis—Dexamethasone—multiple sclerosis	0.00139	0.00562	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Betamethasone—multiple sclerosis	0.00139	0.00562	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Cladribine—multiple sclerosis	0.00131	0.00533	CcSEcCtD
Aminosalicylic Acid—Flatulence—Cladribine—multiple sclerosis	0.00129	0.00526	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Fingolimod—multiple sclerosis	0.00129	0.00525	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Azathioprine—multiple sclerosis	0.00128	0.00518	CcSEcCtD
Aminosalicylic Acid—Dizziness—Fingolimod—multiple sclerosis	0.00125	0.00508	CcSEcCtD
Aminosalicylic Acid—Anaemia—Cladribine—multiple sclerosis	0.00121	0.00493	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Triamcinolone—multiple sclerosis	0.00121	0.00491	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Prednisone—multiple sclerosis	0.00121	0.0049	CcSEcCtD
Aminosalicylic Acid—Headache—Fingolimod—multiple sclerosis	0.00118	0.00481	CcSEcCtD
Aminosalicylic Acid—Purpura—Triamcinolone—multiple sclerosis	0.00112	0.00456	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Mitoxantrone—multiple sclerosis	0.00112	0.00455	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00111	0.00451	CcSEcCtD
Aminosalicylic Acid—Jaundice—Mitoxantrone—multiple sclerosis	0.00108	0.00437	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Cladribine—multiple sclerosis	0.00105	0.00427	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Cladribine—multiple sclerosis	0.00105	0.00426	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Cladribine—multiple sclerosis	0.00104	0.00423	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00103	0.00419	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Prednisolone—multiple sclerosis	0.00102	0.00416	CcSEcCtD
Aminosalicylic Acid—Anorexia—Cladribine—multiple sclerosis	0.00102	0.00415	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Methotrexate—multiple sclerosis	0.00101	0.00409	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Mitoxantrone—multiple sclerosis	0.000992	0.00403	CcSEcCtD
Aminosalicylic Acid—Anaemia—Azathioprine—multiple sclerosis	0.000987	0.00401	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Azathioprine—multiple sclerosis	0.000956	0.00388	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Prednisone—multiple sclerosis	0.000955	0.00388	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Triamcinolone—multiple sclerosis	0.000941	0.00382	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Methylprednisolone—multiple sclerosis	0.000939	0.00381	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Cladribine—multiple sclerosis	0.000932	0.00378	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000926	0.00376	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000903	0.00367	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.000889	0.00361	CcSEcCtD
Aminosalicylic Acid—Purpura—Prednisone—multiple sclerosis	0.000887	0.0036	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000877	0.00356	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000876	0.0957	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000862	0.0942	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000862	0.0942	CbGdCrCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.000855	0.00347	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000853	0.00347	CcSEcCtD
Aminosalicylic Acid—Urticaria—Cladribine—multiple sclerosis	0.000852	0.00346	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Cladribine—multiple sclerosis	0.000847	0.00344	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Cladribine—multiple sclerosis	0.000847	0.00344	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Azathioprine—multiple sclerosis	0.000847	0.00344	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Mitoxantrone—multiple sclerosis	0.000846	0.00343	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000842	0.0921	CbGdCrCtD
Aminosalicylic Acid—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.000817	0.00332	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000815	0.00331	CcSEcCtD
Aminosalicylic Acid—Anaemia—Mitoxantrone—multiple sclerosis	0.000798	0.00324	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Cladribine—multiple sclerosis	0.00079	0.00321	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Mitoxantrone—multiple sclerosis	0.000773	0.00314	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Dexamethasone—multiple sclerosis	0.000767	0.00312	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Betamethasone—multiple sclerosis	0.000767	0.00312	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000757	0.00307	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000753	0.00306	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Prednisone—multiple sclerosis	0.000744	0.00302	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000741	0.00301	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000741	0.00301	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Cladribine—multiple sclerosis	0.000733	0.00298	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000713	0.00289	CcSEcCtD
Aminosalicylic Acid—Dizziness—Cladribine—multiple sclerosis	0.000709	0.00288	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00069	0.0028	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Azathioprine—multiple sclerosis	0.000689	0.0028	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Azathioprine—multiple sclerosis	0.000689	0.0028	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Mitoxantrone—multiple sclerosis	0.000684	0.00278	CcSEcCtD
Aminosalicylic Acid—Vomiting—Cladribine—multiple sclerosis	0.000682	0.00277	CcSEcCtD
Aminosalicylic Acid—Rash—Cladribine—multiple sclerosis	0.000676	0.00274	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Cladribine—multiple sclerosis	0.000675	0.00274	CcSEcCtD
Aminosalicylic Acid—Anorexia—Mitoxantrone—multiple sclerosis	0.000672	0.00273	CcSEcCtD
Aminosalicylic Acid—Headache—Cladribine—multiple sclerosis	0.000672	0.00273	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Prednisone—multiple sclerosis	0.000668	0.00271	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Methylprednisolone—multiple sclerosis	0.00065	0.00264	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000646	0.00262	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Azathioprine—multiple sclerosis	0.000642	0.00261	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Triamcinolone—multiple sclerosis	0.000638	0.00259	CcSEcCtD
Aminosalicylic Acid—Nausea—Cladribine—multiple sclerosis	0.000637	0.00259	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000613	0.00249	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Azathioprine—multiple sclerosis	0.000596	0.00242	CcSEcCtD
Aminosalicylic Acid—Dizziness—Azathioprine—multiple sclerosis	0.000576	0.00234	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000576	0.00234	CcSEcCtD
Aminosalicylic Acid—Urticaria—Mitoxantrone—multiple sclerosis	0.00056	0.00227	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000557	0.00226	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000557	0.00226	CcSEcCtD
Aminosalicylic Acid—Vomiting—Azathioprine—multiple sclerosis	0.000554	0.00225	CcSEcCtD
Aminosalicylic Acid—Rash—Azathioprine—multiple sclerosis	0.00055	0.00223	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00055	0.00223	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Azathioprine—multiple sclerosis	0.000549	0.00223	CcSEcCtD
Aminosalicylic Acid—Headache—Azathioprine—multiple sclerosis	0.000546	0.00222	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00052	0.00211	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000519	0.00211	CcSEcCtD
Aminosalicylic Acid—Nausea—Azathioprine—multiple sclerosis	0.000518	0.0021	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methylprednisolone—multiple sclerosis	0.000515	0.00209	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Prednisone—multiple sclerosis	0.000515	0.00209	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Methotrexate—multiple sclerosis	0.000514	0.00209	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Methotrexate—multiple sclerosis	0.000494	0.00201	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000488	0.00198	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Methotrexate—multiple sclerosis	0.000484	0.00197	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000482	0.00196	CcSEcCtD
Aminosalicylic Acid—Anaemia—Prednisone—multiple sclerosis	0.000476	0.00193	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Betamethasone—multiple sclerosis	0.000473	0.00192	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000473	0.00192	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000472	0.00192	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000472	0.00192	CcSEcCtD
Aminosalicylic Acid—Anorexia—Betamethasone—multiple sclerosis	0.00046	0.00187	CcSEcCtD
Aminosalicylic Acid—Anorexia—Dexamethasone—multiple sclerosis	0.00046	0.00187	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisolone—multiple sclerosis	0.000459	0.00186	CcSEcCtD
Aminosalicylic Acid—Vomiting—Mitoxantrone—multiple sclerosis	0.000448	0.00182	CcSEcCtD
Aminosalicylic Acid—Rash—Mitoxantrone—multiple sclerosis	0.000444	0.0018	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Mitoxantrone—multiple sclerosis	0.000444	0.0018	CcSEcCtD
Aminosalicylic Acid—Headache—Mitoxantrone—multiple sclerosis	0.000441	0.00179	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000435	0.00177	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000434	0.00176	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Methotrexate—multiple sclerosis	0.00043	0.00175	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Prednisolone—multiple sclerosis	0.000426	0.00173	CcSEcCtD
Aminosalicylic Acid—Urticaria—Triamcinolone—multiple sclerosis	0.000422	0.00171	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methylprednisolone—multiple sclerosis	0.000421	0.00171	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Methotrexate—multiple sclerosis	0.000421	0.00171	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Triamcinolone—multiple sclerosis	0.00042	0.00171	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000419	0.0017	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Dexamethasone—multiple sclerosis	0.000419	0.0017	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Betamethasone—multiple sclerosis	0.000419	0.0017	CcSEcCtD
Aminosalicylic Acid—Nausea—Mitoxantrone—multiple sclerosis	0.000419	0.0017	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000416	0.00169	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000416	0.00169	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Prednisone—multiple sclerosis	0.000412	0.00167	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Prednisone—multiple sclerosis	0.000408	0.00166	CcSEcCtD
Aminosalicylic Acid—Anorexia—Prednisone—multiple sclerosis	0.0004	0.00163	CcSEcCtD
Aminosalicylic Acid—Anaemia—Methotrexate—multiple sclerosis	0.000398	0.00161	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000394	0.0016	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000394	0.0016	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000392	0.00159	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000391	0.00159	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Methotrexate—multiple sclerosis	0.000385	0.00156	CcSEcCtD
Aminosalicylic Acid—Urticaria—Dexamethasone—multiple sclerosis	0.000383	0.00156	CcSEcCtD
Aminosalicylic Acid—Urticaria—Betamethasone—multiple sclerosis	0.000383	0.00156	CcSEcCtD
Aminosalicylic Acid—Dizziness—Prednisolone—multiple sclerosis	0.000382	0.00155	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Betamethasone—multiple sclerosis	0.000381	0.00155	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dexamethasone—multiple sclerosis	0.000381	0.00155	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Dexamethasone—multiple sclerosis	0.000381	0.00155	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Betamethasone—multiple sclerosis	0.000381	0.00155	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Prednisone—multiple sclerosis	0.000365	0.00148	CcSEcCtD
Aminosalicylic Acid—Rash—Prednisolone—multiple sclerosis	0.000365	0.00148	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisolone—multiple sclerosis	0.000364	0.00148	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000364	0.00148	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000363	0.00147	CcSEcCtD
Aminosalicylic Acid—Headache—Prednisolone—multiple sclerosis	0.000362	0.00147	CcSEcCtD
Aminosalicylic Acid—Dizziness—Triamcinolone—multiple sclerosis	0.000352	0.00143	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methylprednisolone—multiple sclerosis	0.000351	0.00142	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Methotrexate—multiple sclerosis	0.000344	0.0014	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000344	0.0014	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000344	0.00139	CcSEcCtD
Aminosalicylic Acid—Nausea—Prednisolone—multiple sclerosis	0.000343	0.00139	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methotrexate—multiple sclerosis	0.000341	0.00138	CcSEcCtD
Aminosalicylic Acid—Vomiting—Triamcinolone—multiple sclerosis	0.000338	0.00137	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methylprednisolone—multiple sclerosis	0.000337	0.00137	CcSEcCtD
Aminosalicylic Acid—Rash—Triamcinolone—multiple sclerosis	0.000335	0.00136	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Triamcinolone—multiple sclerosis	0.000335	0.00136	CcSEcCtD
Aminosalicylic Acid—Anorexia—Methotrexate—multiple sclerosis	0.000335	0.00136	CcSEcCtD
Aminosalicylic Acid—Rash—Methylprednisolone—multiple sclerosis	0.000334	0.00136	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methylprednisolone—multiple sclerosis	0.000334	0.00136	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisone—multiple sclerosis	0.000334	0.00135	CcSEcCtD
Aminosalicylic Acid—Headache—Triamcinolone—multiple sclerosis	0.000333	0.00135	CcSEcCtD
Aminosalicylic Acid—Headache—Methylprednisolone—multiple sclerosis	0.000332	0.00135	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Prednisone—multiple sclerosis	0.000332	0.00135	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Prednisone—multiple sclerosis	0.000332	0.00135	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Dexamethasone—multiple sclerosis	0.00033	0.00134	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Betamethasone—multiple sclerosis	0.00033	0.00134	CcSEcCtD
Aminosalicylic Acid—Dizziness—Dexamethasone—multiple sclerosis	0.000319	0.0013	CcSEcCtD
Aminosalicylic Acid—Dizziness—Betamethasone—multiple sclerosis	0.000319	0.0013	CcSEcCtD
Aminosalicylic Acid—Nausea—Triamcinolone—multiple sclerosis	0.000316	0.00128	CcSEcCtD
Aminosalicylic Acid—Nausea—Methylprednisolone—multiple sclerosis	0.000315	0.00128	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Prednisone—multiple sclerosis	0.00031	0.00126	CcSEcCtD
Aminosalicylic Acid—Vomiting—Betamethasone—multiple sclerosis	0.000307	0.00125	CcSEcCtD
Aminosalicylic Acid—Vomiting—Dexamethasone—multiple sclerosis	0.000307	0.00125	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Methotrexate—multiple sclerosis	0.000305	0.00124	CcSEcCtD
Aminosalicylic Acid—Rash—Dexamethasone—multiple sclerosis	0.000304	0.00123	CcSEcCtD
Aminosalicylic Acid—Rash—Betamethasone—multiple sclerosis	0.000304	0.00123	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Dexamethasone—multiple sclerosis	0.000304	0.00123	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Betamethasone—multiple sclerosis	0.000304	0.00123	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000303	0.00123	CcSEcCtD
Aminosalicylic Acid—Headache—Betamethasone—multiple sclerosis	0.000302	0.00123	CcSEcCtD
Aminosalicylic Acid—Headache—Dexamethasone—multiple sclerosis	0.000302	0.00123	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Prednisone—multiple sclerosis	0.000287	0.00117	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000287	0.00117	CcSEcCtD
Aminosalicylic Acid—Nausea—Dexamethasone—multiple sclerosis	0.000287	0.00116	CcSEcCtD
Aminosalicylic Acid—Nausea—Betamethasone—multiple sclerosis	0.000287	0.00116	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methotrexate—multiple sclerosis	0.000279	0.00113	CcSEcCtD
Aminosalicylic Acid—Dizziness—Prednisone—multiple sclerosis	0.000278	0.00113	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methotrexate—multiple sclerosis	0.000278	0.00113	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Methotrexate—multiple sclerosis	0.000278	0.00113	CcSEcCtD
Aminosalicylic Acid—Vomiting—Prednisone—multiple sclerosis	0.000267	0.00108	CcSEcCtD
Aminosalicylic Acid—Rash—Prednisone—multiple sclerosis	0.000265	0.00108	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisone—multiple sclerosis	0.000265	0.00107	CcSEcCtD
Aminosalicylic Acid—Headache—Prednisone—multiple sclerosis	0.000263	0.00107	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methotrexate—multiple sclerosis	0.000259	0.00105	CcSEcCtD
Aminosalicylic Acid—Nausea—Prednisone—multiple sclerosis	0.00025	0.00101	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methotrexate—multiple sclerosis	0.00024	0.000975	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methotrexate—multiple sclerosis	0.000232	0.000943	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methotrexate—multiple sclerosis	0.000223	0.000906	CcSEcCtD
Aminosalicylic Acid—Rash—Methotrexate—multiple sclerosis	0.000221	0.000899	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methotrexate—multiple sclerosis	0.000221	0.000898	CcSEcCtD
Aminosalicylic Acid—Headache—Methotrexate—multiple sclerosis	0.00022	0.000893	CcSEcCtD
Aminosalicylic Acid—Nausea—Methotrexate—multiple sclerosis	0.000209	0.000847	CcSEcCtD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—MAPK1—multiple sclerosis	0.000146	0.000462	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 dependent cascade initiated on endosome—IL6—multiple sclerosis	0.000146	0.000461	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—ICAM1—multiple sclerosis	0.000145	0.00046	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD28—multiple sclerosis	0.000145	0.000458	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—IL6—multiple sclerosis	0.000143	0.000453	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—STAT3—multiple sclerosis	0.000143	0.000453	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PTPRC—multiple sclerosis	0.000142	0.00045	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CBLB—multiple sclerosis	0.000142	0.000448	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—STAT3—multiple sclerosis	0.000141	0.000445	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—multiple sclerosis	0.000141	0.000445	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—IL6—multiple sclerosis	0.000141	0.000445	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—multiple sclerosis	0.000138	0.000438	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CD80—multiple sclerosis	0.000138	0.000435	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DPB1—multiple sclerosis	0.000137	0.000435	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IFNB1—multiple sclerosis	0.000137	0.000432	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000136	0.000429	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	0.000135	0.000427	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—ALB—multiple sclerosis	0.000134	0.000425	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TAGAP—multiple sclerosis	0.000134	0.000425	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—IL6—multiple sclerosis	0.000133	0.00042	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ITGA4—multiple sclerosis	0.000132	0.000418	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD40—multiple sclerosis	0.000132	0.000418	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—MAPK1—multiple sclerosis	0.000132	0.000416	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	0.000131	0.000414	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CTLA4—multiple sclerosis	0.00013	0.000412	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—MAPK1—multiple sclerosis	0.00013	0.000412	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—MAPK1—multiple sclerosis	0.00013	0.000412	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.00013	0.00041	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—IL6—multiple sclerosis	0.00013	0.00041	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—STAT3—multiple sclerosis	0.000129	0.000407	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—MAPK1—multiple sclerosis	0.000128	0.000405	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	0.000126	0.000398	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MX1—multiple sclerosis	0.000126	0.000398	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SRM—multiple sclerosis	0.000125	0.000397	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TNF—multiple sclerosis	0.000125	0.000397	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—MAPK1—multiple sclerosis	0.000125	0.000394	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL6—multiple sclerosis	0.000124	0.000392	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	0.000123	0.00039	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—MAPK1—multiple sclerosis	0.000123	0.000388	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DRA—multiple sclerosis	0.000122	0.000385	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—IL6—multiple sclerosis	0.000119	0.000378	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—STAT3—multiple sclerosis	0.000119	0.000378	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	0.000119	0.000377	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000118	0.000374	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—TYK2—multiple sclerosis	0.000118	0.000374	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—S1PR1—multiple sclerosis	0.000117	0.000371	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—MAPK1—multiple sclerosis	0.000117	0.00037	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—STAT3—multiple sclerosis	0.000117	0.000369	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	0.000117	0.000369	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—MAPK1—multiple sclerosis	0.000116	0.000368	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	0.000116	0.000368	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—TYK2—multiple sclerosis	0.000116	0.000367	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—MAPK1—multiple sclerosis	0.000116	0.000367	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—MAPK1—multiple sclerosis	0.000115	0.000365	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—VCAM1—multiple sclerosis	0.000115	0.000364	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NOD1—multiple sclerosis	0.000115	0.000363	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DQA1—multiple sclerosis	0.000115	0.000363	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GPC5—multiple sclerosis	0.000114	0.000361	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—multiple sclerosis	0.000112	0.000355	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—BCHE—multiple sclerosis	0.000112	0.000354	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP24A1—multiple sclerosis	0.000111	0.000352	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP27B1—multiple sclerosis	0.000111	0.000352	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MALT1—multiple sclerosis	0.000111	0.000351	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IFNG—multiple sclerosis	0.000111	0.00035	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	0.00011	0.000348	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IRF5—multiple sclerosis	0.000109	0.000345	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000109	0.000344	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000109	0.000344	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—MAPK1—multiple sclerosis	0.000109	0.000343	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—MAPK1—multiple sclerosis	0.000109	0.000343	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—MAPK1—multiple sclerosis	0.000109	0.000343	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD86—multiple sclerosis	0.000108	0.00034	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—MAPK1—multiple sclerosis	0.000108	0.00034	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DQB1—multiple sclerosis	0.000107	0.000339	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	0.000107	0.000339	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—MAPK1—multiple sclerosis	0.000107	0.000337	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—MAPK1—multiple sclerosis	0.000106	0.000336	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RPL5—multiple sclerosis	0.000106	0.000335	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—STAT3—multiple sclerosis	0.000106	0.000334	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	0.000104	0.00033	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFIH1—multiple sclerosis	0.000104	0.00033	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IRF8—multiple sclerosis	0.000104	0.00033	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-G—multiple sclerosis	0.000104	0.00033	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	0.000104	0.000329	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD86—multiple sclerosis	0.000103	0.000327	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	0.000102	0.000323	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GPC5—multiple sclerosis	0.000102	0.000322	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SLC11A1—multiple sclerosis	0.000102	0.000321	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD40LG—multiple sclerosis	0.000101	0.00032	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—IL6—multiple sclerosis	0.000101	0.00032	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HLA-B—multiple sclerosis	0.0001	0.000317	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD8A—multiple sclerosis	0.0001	0.000317	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—IL6—multiple sclerosis	0.0001	0.000316	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—IL6—multiple sclerosis	0.0001	0.000316	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RGS1—multiple sclerosis	9.98e-05	0.000316	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL1B—multiple sclerosis	9.87e-05	0.000312	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL2—multiple sclerosis	9.83e-05	0.000311	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TNFAIP3—multiple sclerosis	9.76e-05	0.000309	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.72e-05	0.000308	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GPC5—multiple sclerosis	9.66e-05	0.000305	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-B—multiple sclerosis	9.63e-05	0.000305	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—MAPK1—multiple sclerosis	9.61e-05	0.000304	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—IL6—multiple sclerosis	9.57e-05	0.000303	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GPR65—multiple sclerosis	9.46e-05	0.000299	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—IL6—multiple sclerosis	9.42e-05	0.000298	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	9.09e-05	0.000287	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	9.07e-05	0.000287	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—IL6—multiple sclerosis	8.99e-05	0.000285	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—IL6—multiple sclerosis	8.95e-05	0.000283	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-A—multiple sclerosis	8.93e-05	0.000282	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—IL6—multiple sclerosis	8.91e-05	0.000282	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	8.89e-05	0.000281	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—IL6—multiple sclerosis	8.86e-05	0.00028	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP24A1—multiple sclerosis	8.84e-05	0.00028	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP27B1—multiple sclerosis	8.84e-05	0.00028	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD28—multiple sclerosis	8.78e-05	0.000278	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR1—multiple sclerosis	8.65e-05	0.000274	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL13—multiple sclerosis	8.65e-05	0.000274	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.64e-05	0.000273	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	8.64e-05	0.000273	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CCR2—multiple sclerosis	8.62e-05	0.000273	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTPRC—multiple sclerosis	8.62e-05	0.000273	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TLR4—multiple sclerosis	8.5e-05	0.000269	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	8.46e-05	0.000268	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—RRM1—multiple sclerosis	8.44e-05	0.000267	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—multiple sclerosis	8.34e-05	0.000264	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—IL6—multiple sclerosis	8.34e-05	0.000264	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—IL6—multiple sclerosis	8.34e-05	0.000264	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DPB1—multiple sclerosis	8.33e-05	0.000264	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—STAT3—multiple sclerosis	8.27e-05	0.000262	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—IL6—multiple sclerosis	8.26e-05	0.000261	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—IL6—multiple sclerosis	8.19e-05	0.000259	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DRB1—multiple sclerosis	8.15e-05	0.000258	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—IL6—multiple sclerosis	8.15e-05	0.000258	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—STAT3—multiple sclerosis	8.13e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD28—multiple sclerosis	8.11e-05	0.000256	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GPC5—multiple sclerosis	8.09e-05	0.000256	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ITGA4—multiple sclerosis	8.02e-05	0.000254	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD40—multiple sclerosis	8.02e-05	0.000254	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNB1—multiple sclerosis	7.96e-05	0.000252	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTLA4—multiple sclerosis	7.9e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD80—multiple sclerosis	7.85e-05	0.000248	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ICAM1—multiple sclerosis	7.83e-05	0.000248	CbGpPWpGaD
Aminosalicylic Acid—Diflunisal—ALB—multiple sclerosis	7.56e-05	0.643	CrCbGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD80—multiple sclerosis	7.53e-05	0.000238	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—MAPK1—multiple sclerosis	7.52e-05	0.000238	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—MAPK1—multiple sclerosis	7.39e-05	0.000234	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	7.38e-05	0.000234	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—VCAM1—multiple sclerosis	6.97e-05	0.000221	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DQA1—multiple sclerosis	6.95e-05	0.00022	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	6.83e-05	0.000216	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—APOE—multiple sclerosis	6.73e-05	0.000213	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—RRM1—multiple sclerosis	6.7e-05	0.000212	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TYK2—multiple sclerosis	6.62e-05	0.00021	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.55e-05	0.000207	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DQB1—multiple sclerosis	6.51e-05	0.000206	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RPL5—multiple sclerosis	6.28e-05	0.000199	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD86—multiple sclerosis	6.26e-05	0.000198	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	6.18e-05	0.000196	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	6.17e-05	0.000195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL3—multiple sclerosis	6.16e-05	0.000195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD40LG—multiple sclerosis	6.14e-05	0.000194	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD8A—multiple sclerosis	6.07e-05	0.000192	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	6.05e-05	0.000191	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC11A1—multiple sclerosis	6.01e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD4—multiple sclerosis	5.99e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTGER4—multiple sclerosis	5.93e-05	0.000188	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-B—multiple sclerosis	5.84e-05	0.000185	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PGR—multiple sclerosis	5.84e-05	0.000185	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD86—multiple sclerosis	5.78e-05	0.000183	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—POMC—multiple sclerosis	5.78e-05	0.000183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL6—multiple sclerosis	5.78e-05	0.000183	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	5.76e-05	0.000182	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD4—multiple sclerosis	5.75e-05	0.000182	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCR3—multiple sclerosis	5.73e-05	0.000181	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6—multiple sclerosis	5.68e-05	0.00018	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CD28—multiple sclerosis	5.68e-05	0.00018	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.63e-05	0.000178	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR2—multiple sclerosis	5.57e-05	0.000176	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2RA—multiple sclerosis	5.48e-05	0.000173	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-A—multiple sclerosis	5.41e-05	0.000171	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ALB—multiple sclerosis	5.27e-05	0.000167	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.2e-05	0.000164	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CNR1—multiple sclerosis	5.14e-05	0.000163	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CCR5—multiple sclerosis	5.13e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.13e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HLA-A—multiple sclerosis	5e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TLR4—multiple sclerosis	4.95e-05	0.000157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DRB1—multiple sclerosis	4.95e-05	0.000156	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—BCHE—multiple sclerosis	4.85e-05	0.000153	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD28—multiple sclerosis	4.8e-05	0.000152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ICAM1—multiple sclerosis	4.75e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOE—multiple sclerosis	4.67e-05	0.000148	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL10—multiple sclerosis	4.63e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD80—multiple sclerosis	4.57e-05	0.000145	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.47e-05	0.000141	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD80—multiple sclerosis	4.22e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MAPK1—multiple sclerosis	4.22e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—Salicylic acid—ALB—multiple sclerosis	4.21e-05	0.357	CrCbGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.07e-05	0.000129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CD86—multiple sclerosis	4.05e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL5—multiple sclerosis	3.99e-05	0.000126	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TYK2—multiple sclerosis	3.86e-05	0.000122	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—BCHE—multiple sclerosis	3.85e-05	0.000122	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SPP1—multiple sclerosis	3.69e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNG—multiple sclerosis	3.61e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR5—multiple sclerosis	3.59e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TYK2—multiple sclerosis	3.56e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2RA—multiple sclerosis	3.54e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD4—multiple sclerosis	3.49e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD86—multiple sclerosis	3.43e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOE—multiple sclerosis	3.27e-05	0.000103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—multiple sclerosis	3.24e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1B—multiple sclerosis	3.22e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD4—multiple sclerosis	3.22e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—multiple sclerosis	3.21e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CCR5—multiple sclerosis	3.04e-05	9.61e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HLA-A—multiple sclerosis	2.96e-05	9.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CD80—multiple sclerosis	2.95e-05	9.35e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOE—multiple sclerosis	2.92e-05	9.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—POMC—multiple sclerosis	2.81e-05	8.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOE—multiple sclerosis	2.76e-05	8.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL2—multiple sclerosis	2.75e-05	8.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—STAT3—multiple sclerosis	2.7e-05	8.55e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—POMC—multiple sclerosis	2.51e-05	7.93e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD80—multiple sclerosis	2.5e-05	7.91e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TYK2—multiple sclerosis	2.49e-05	7.89e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—STAT3—multiple sclerosis	2.49e-05	7.89e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK1—multiple sclerosis	2.46e-05	7.77e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—multiple sclerosis	2.32e-05	7.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOE—multiple sclerosis	2.32e-05	7.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—multiple sclerosis	2.31e-05	7.31e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALB—multiple sclerosis	2.28e-05	7.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAPK1—multiple sclerosis	2.27e-05	7.17e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TYK2—multiple sclerosis	2.11e-05	6.67e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—multiple sclerosis	2.08e-05	6.57e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—POMC—multiple sclerosis	1.99e-05	6.29e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP9—multiple sclerosis	1.96e-05	6.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD4—multiple sclerosis	1.91e-05	6.04e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—multiple sclerosis	1.89e-05	5.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALB—multiple sclerosis	1.81e-05	5.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT3—multiple sclerosis	1.75e-05	5.52e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—multiple sclerosis	1.74e-05	5.51e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—multiple sclerosis	1.62e-05	5.13e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—multiple sclerosis	1.62e-05	5.12e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK1—multiple sclerosis	1.59e-05	5.02e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT3—multiple sclerosis	1.48e-05	4.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—multiple sclerosis	1.37e-05	4.34e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—multiple sclerosis	1.37e-05	4.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAPK1—multiple sclerosis	1.34e-05	4.25e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—multiple sclerosis	1.22e-05	3.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—multiple sclerosis	1.03e-05	3.26e-05	CbGpPWpGaD
